Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma

Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma

Background Previous studies have suggested the potential synergistic antitumor activity when combining immune checkpoint inhibitors with anti-angiogenic agents in various solid tumors. We aimed to assess the efficacy and safety of camrelizumab (a humanized programmed cell death-1 antibody) plus apat...

Full description

Saved in:
Bibliographic Details
Main Authors: Lin Li, Rong Huang, Huizi Sha, Baorui Liu, Zhengyun Zou, Guiying Zhang, Yu Ren, Fufeng Wang, Jiayu Wang, Lianjun Zhao, Kelin Zheng, Mengke Zhao, Donglin Kang, Xinyu Su, Yirong Wu, Wangling Zhang, Ruihe Lai, Rui Mei, Yitao Wang, You Tian
Format: Article
Language:English
Published: BMJ Publishing Group 2024-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/6/e008611.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items